CCB
ENZ

Cutter & Co Brokerage’s Enzo Biochem, Inc. ENZ Stock Holding History

Cutter & Co Brokerage’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,500
Closed -$28.5K – 221
2023
Q2 		$28.5K Hold
15,500
– – 0.01% 207
2023
Q1 		$37.7K Sell
15,500
-2,206
-12% -$3.28K 0.01% 209
2022
Q4 		$25.3K Sell
17,706
-4,071
-19% -$7.93K 0.01% 209
2022
Q3 		$49K Hold
21,777
– – 0.02% 215
2022
Q2 		$45K Sell
21,777
-4,000
-16% -$9.89K 0.02% 220
2022
Q1 		$75K Sell
25,777
-2,000
-7% -$6.42K 0.02% 222
2021
Q4 		$89K Sell
27,777
-50
-0.2% -$171 0.02% 265
2021
Q3 		$99K Buy
27,827
+2,000
+8% +$6.67K 0.02% 283
2021
Q2 		$82K Sell
25,827
-4,000
-13% -$12.6K 0.02% 292
2021
Q1 		$103K Hold
29,827
– – 0.03% 280
2020
Q4 		$75K Hold
29,827
– – 0.02% 263
2020
Q3 		$63K Buy
29,827
+3,000
+11% +$7.13K 0.02% 244
2020
Q2 		$60K Buy
26,827
+5,000
+23% +$12.9K 0.02% 228
2020
Q1 		$55K Buy
21,827
+3,000
+16% +$7.37K 0.02% 213
2019
Q4 		$50K Hold
18,827
– – 0.02% 244
2019
Q3 		$68K Hold
18,827
– – 0.02% 288
2019
Q2 		$63K Hold
18,827
– – 0.02% 292
2019
Q1 		$51K Buy
18,827
+3,000
+19% +$9.82K 0.01% 286
2018
Q4 		$44K Buy
15,827
+3,000
+23% +$9.83K 0.02% 260
2018
Q3 		$53K Buy
12,827
+1,000
+8% +$4.54K 0.02% 276
2018
Q2 		$61K Sell
11,827
-1,165
-9% -$7.1K 0.02% 239
2018
Q1 		$71K Sell
12,992
-2,000
-13% -$14.1K 0.03% 243
2017
Q4 		$122K Buy
14,992
+1,000
+7% +$9.55K 0.05% 233
2017
Q3 		$146K Buy
13,992
+1,000
+8% +$11.1K 0.06% 239
2017
Q2 		$143K Hold
12,992
– – 0.06% 247
2017
Q1 		$109K Hold
12,992
– – 0.05% 243
2016
Q4 		$90K Hold
12,992
– – 0.04% 230
2016
Q3 		$66K Sell
12,992
-211
-2% -$1.26K 0.03% 234
2016
Q2 		$79K Hold
13,203
– – 0.03% 223
2016
Q1 		$60K Buy
13,203
+1,000
+8% +$4.45K 0.03% 227
2015
Q4 		$55K Buy
12,203
+1,000
+9% +$4.22K 0.03% 210
2015
Q3 		$36K Buy
11,203
+1,000
+10% +$3.03K 0.02% 210
2015
Q2 		$31K Buy
+10,203
New +$28.7K 0.01% 249

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Cutter & Co Brokerage's ENZ Position: Q3 2023 in Review

Cutter & Co Brokerage sold out of Enzo Biochem, Inc. (ENZ) in Q3 2023, closing a stake of 15,500 shares — an estimated $28.5K sold.

Cutter & Co Brokerage first reported a position in ENZ in Q2 2015 and held it in 33 quarters. The position peaked at $146K in Q3 2017. 39 funds tracked by Wall St. Rank hold ENZ as of Q3 2023.

  • Cutter & Co Brokerage reported no remaining Enzo Biochem, Inc. position as of Q3 2023 after selling out during the quarter.
  • Cutter & Co Brokerage sold 15,500 Enzo Biochem, Inc. shares in Q3 2023, an estimated $28.5K.
  • Cutter & Co Brokerage first reported a position in Enzo Biochem, Inc. in Q2 2015 and held it in 33 quarters.
  • Cutter & Co Brokerage's Enzo Biochem, Inc. position peaked at $146K in Q3 2017.
  • 39 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2023.

Based on Cutter & Co Brokerage's 13F filing for Q3 2023, filed 31 Oct 2023.